Severe recalcitrant pyoderma gangrenosum treated with infliximab
Authors:
- 5 August 2005
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 153 (3) , 689-691
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumabJournal of Dermatological Treatment, 2004
- Infliximab as a treatment for recalcitrant pyoderma gangrenosumClinical and Experimental Dermatology, 2004
- Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel diseaseAmerican Journal of Gastroenterology, 2003
- Corticosteroid-Resistant Pyoderma gangrenosum Associated with Crohn’s Disease: Rapid Cure with InfliximabDermatology, 2002
- Favorable Response to Infliximab Treatment in a Patient with Active Crohn Disease and Pyoderma GangrenosumScandinavian Journal of Gastroenterology, 2002
- Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritisBritish Journal of Dermatology, 2001
- Pyoderma Gangrenosum A Comparison of Typical and Atypical Forms with an Emphasis on Time to Remission. Case Review of 86 Patients from 2 InstitutionsMedicine, 2000